ArticleExperimental and therapeutic medicine2019

Overexpression of microRNA-620 facilitates the resistance of triple negative breast cancer cells to gemcitabine treatment by targeting DCTD.

Chao Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.